UniProt ID | WNK2_HUMAN | |
---|---|---|
UniProt AC | Q9Y3S1 | |
Protein Name | Serine/threonine-protein kinase WNK2 {ECO:0000305} | |
Gene Name | WNK2 {ECO:0000312|HGNC:HGNC:14542} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 2297 | |
Subcellular Localization | Cytoplasm . Cell membrane . | |
Protein Description | Serine/threonine kinase which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation. Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively. Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5. Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression. Affects MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this modulation depends on phosphorylation of MAP2K1 by PAK1. WNK2 acts by interfering with the activity of PAK1 by controlling the balance of the activity of upstream regulators of PAK1 activity, RHOA and RAC1, which display reciprocal activity.. | |
Protein Sequence | MDGDGGRRDVPGTLMEPGRGAGPAGMAEPRAKAARPGPQRFLRRSVVESDQEEPPGLEAAEAPGPQPPQPLQRRVLLLCKTRRLIAERARGRPAAPAPAALVAQPGAPGAPADAGPEPVGTQEPGPDPIAAAVETAPAPDGGPREEAAATVRKEDEGAAEAKPEPGRTRRDEPEEEEDDEDDLKAVATSLDGRFLKFDIELGRGSFKTVYKGLDTETWVEVAWCELQDRKLTKLERQRFKEEAEMLKGLQHPNIVRFYDFWESSAKGKRCIVLVTELMTSGTLKTYLKRFKVMKPKVLRSWCRQILKGLLFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKSVIGTPEFMAPEMYEEHYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRKVTCGIKPASFEKVHDPEIKEIIGECICKNKEERYEIKDLLSHAFFAEDTGVRVELAEEDHGRKSTIALRLWVEDPKKLKGKPKDNGAIEFTFDLEKETPDEVAQEMIESGFFHESDVKIVAKSIRDRVALIQWRRERIWPALQPKEQQDVGSPDKARGPPVPLQVQVTYHAQAGQPGPPEPEEPEADQHLLPPTLPTSATSLASDSTFDSGQGSTVYSDSQSSQQSVMLGSLADAAPSPAQCVCSPPVSEGPVLPQSLPSLGAYQQPTAAPGLPVGSVPAPACPPSLQQHFPDPAMSFAPVLPPPSTPMPTGPGQPAPPGQQPPPLAQPTPLPQVLAPQPVVPLQPVPPHLPPYLAPASQVGAPAQLKPLQMPQAPLQPLAQVPPQMPPIPVVPPITPLAGIDGLPPALPDLPTATVPPVPPPQYFSPAVILPSLAAPLPPASPALPLQAVKLPHPPGAPLAMPCRTIVPNAPATIPLLAVAPPGVAALSIHSAVAQLPGQPVYPAAFPQMAPTDVPPSPHHTVQNMRATPPQPALPPQPTLPPQPVLPPQPTLPPQPVLPPQPTRPPQPVLPPQPMLPPQPVLPPQPALPVRPEPLQPHLPEQAAPAATPGSQILLGHPAPYAVDVAAQVPTVPVPPAAVLSPPLPEVLLPAAPELLPQFPSSLATVSASVQSVPTQTATLLPPANPPLPGGPGIASPCPTVQLTVEPVQEEQASQDKPPGLPQSCESYGGSDVTSGKELSDSCEGAFGGGRLEGRAARKHHRRSTRARSRQERASRPRLTILNVCNTGDKMVECQLETHNHKMVTFKFDLDGDAPDEIATYMVEHDFILQAERETFIEQMKDVMDKAEDMLSEDTDADRGSDPGTSPPHLSTCGLGTGEESRQSQANAPVYQQNVLHTGKRWFIICPVAEHPAPEAPESSPPLPLSSLPPEASQGPCRGLTLPCLPWRRAACGAVFLSLFSAESAQSKQPPDSAPYKDQLSSKEQPSFLASQQLLSQAGPSNPPGAPPAPLAPSSPPVTALPQDGAAPATSTMPEPASGTASQAGGPGTPQGLTSELETSQPLAETHEAPLAVQPLVVGLAPCTPAPEAASTRDASAPREPLPPPAPEPSPHSGTPQPALGQPAPLLPAAVGAVSLATSQLPSPPLGPTVPPQPPSALESDGEGPPPRVGFVDSTIKSLDEKLRTLLYQEHVPTSSASAGTPVEVGDRDFTLEPLRGDQPRSEVCGGDLALPPVPKEAVSGRVQLPQPLVEKSELAPTRGAVMEQGTSSSMTAESSPRSMLGYDRDGRQVASDSHVVPSVPQDVPAFVRPARVEPTDRDGGEAGESSAEPPPSDMGTVGGQASHPQTLGARALGSPRKRPEQQDVSSPAKTVGRFSVVSTQDEWTLASPHSLRYSAPPDVYLDEAPSSPDVKLAVRRAQTASSIEVGVGEPVSSDSGDEGPRARPPVQKQASLPVSGSVAGDFVKKATAFLQRPSRAGSLGPETPSRVGMKVPTISVTSFHSQSSYISSDNDSELEDADIKKELQSLREKHLKEISELQSQQKQEIEALYRRLGKPLPPNVGFFHTAPPTGRRRKTSKSKLKAGKLLNPLVRQLKVVASSTGHLADSSRGPPAKDPAQASVGLTADSTGLSGKAVQTQQPCSVRASLSSDICSGLASDGGGARGQGWTVYHPTSERVTYKSSSKPRARFLSGPVSVSIWSALKRLCLGKEHSSRSSTSSLAPGPEPGPQPALHVQAQVNNSNNKKGTFTDDLHKLVDEWTSKTVGAAQLKPTLNQLKQTQKLQDMEAQAGWAAPGEARAMTAPRAGVGMPRLPPAPGPLSTTVIPGAAPTLSVPTPDGALGTARRNQVWFGLRVPPTACCGHSTQPRGGQRVGSKTASFAASDPVRS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | GRRDVPGTLMEPGRG CCCCCCCCCCCCCCC | 19.50 | - | |
19 | Methylation | GTLMEPGRGAGPAGM CCCCCCCCCCCCCCC | 42.37 | 16226709 | |
30 | Methylation | PAGMAEPRAKAARPG CCCCCCHHHHHCCCC | 39.98 | - | |
45 | Phosphorylation | PQRFLRRSVVESDQE HHHHHHHHHHCCCCC | 24.87 | 21955146 | |
49 | Phosphorylation | LRRSVVESDQEEPPG HHHHHHCCCCCCCCC | 32.74 | 30175587 | |
210 | Phosphorylation | RGSFKTVYKGLDTET CCCEEEEECCCCHHH | 12.45 | - | |
232 | Phosphorylation | ELQDRKLTKLERQRF HHHHHCCHHHHHHHH | 36.30 | - | |
275 | Phosphorylation | KRCIVLVTELMTSGT CCEEEEEEECCCCCH | 21.17 | 30387612 | |
280 | Phosphorylation | LVTELMTSGTLKTYL EEEECCCCCHHHHHH | 18.80 | 24719451 | |
282 | Phosphorylation | TELMTSGTLKTYLKR EECCCCCHHHHHHHH | 25.50 | 24719451 | |
286 | Phosphorylation | TSGTLKTYLKRFKVM CCCHHHHHHHHHCCC | 14.51 | 30387612 | |
300 | Phosphorylation | MKPKVLRSWCRQILK CCHHHHHHHHHHHHH | 26.77 | 22964224 | |
347 | Phosphorylation | IGDLGLATLKRASFA ECHHHHHHHHHHHHH | 37.54 | 21406692 | |
349 | Ubiquitination | DLGLATLKRASFAKS HHHHHHHHHHHHHHH | 41.38 | - | |
352 | Phosphorylation | LATLKRASFAKSVIG HHHHHHHHHHHHHHC | 29.75 | 17081983 | |
356 | Phosphorylation | KRASFAKSVIGTPEF HHHHHHHHHHCCCCH | 18.61 | 25850435 | |
391 | Phosphorylation | MCMLEMATSEYPYSE HHHHHHHHCCCCHHH | 22.30 | 26552605 | |
392 | Phosphorylation | CMLEMATSEYPYSEC HHHHHHHCCCCHHHH | 26.12 | 26552605 | |
394 | Phosphorylation | LEMATSEYPYSECQN HHHHHCCCCHHHHCC | 13.77 | 26552605 | |
396 | Phosphorylation | MATSEYPYSECQNAA HHHCCCCHHHHCCHH | 19.05 | 26552605 | |
397 | Phosphorylation | ATSEYPYSECQNAAQ HHCCCCHHHHCCHHH | 27.65 | 26552605 | |
406 | Phosphorylation | CQNAAQIYRKVTCGI HCCHHHHHHHHCCCC | 7.72 | 26552605 | |
442 | Phosphorylation | CKNKEERYEIKDLLS HCCHHHHHHHHHHHH | 25.86 | 22817900 | |
473 | Phosphorylation | EDHGRKSTIALRLWV CCCCCCCEEEEEEEE | 17.19 | 24719451 | |
560 | Phosphorylation | KEQQDVGSPDKARGP HHHCCCCCCCCCCCC | 29.76 | 25159151 | |
1150 | Phosphorylation | VTSGKELSDSCEGAF CCCCCHHHHCCCCCC | 28.68 | 19664994 | |
1152 | Phosphorylation | SGKELSDSCEGAFGG CCCHHHHCCCCCCCC | 15.64 | 28985074 | |
1175 | Phosphorylation | RKHHRRSTRARSRQE HHHHHHHHHHHHHHH | 26.91 | - | |
1262 | Phosphorylation | DKAEDMLSEDTDADR HHHHHHHCCCCCCCC | 27.13 | 26471730 | |
1265 | Phosphorylation | EDMLSEDTDADRGSD HHHHCCCCCCCCCCC | 29.09 | 27251275 | |
1271 | Phosphorylation | DTDADRGSDPGTSPP CCCCCCCCCCCCCCC | 41.34 | 28348404 | |
1275 | Phosphorylation | DRGSDPGTSPPHLST CCCCCCCCCCCCCCC | 43.37 | 28985074 | |
1276 | Phosphorylation | RGSDPGTSPPHLSTC CCCCCCCCCCCCCCC | 42.20 | 24076635 | |
1281 | Phosphorylation | GTSPPHLSTCGLGTG CCCCCCCCCCCCCCC | 20.72 | 23312004 | |
1282 | Phosphorylation | TSPPHLSTCGLGTGE CCCCCCCCCCCCCCH | 19.56 | 23312004 | |
1287 | Phosphorylation | LSTCGLGTGEESRQS CCCCCCCCCHHHHHH | 46.60 | 23312004 | |
1329 (in isoform 2) | Phosphorylation | - | 47.27 | 28348404 | |
1330 (in isoform 2) | Phosphorylation | - | 28.95 | 28348404 | |
1588 | Phosphorylation | FVDSTIKSLDEKLRT CCHHHHHHHHHHHHH | 36.88 | 23312004 | |
1595 | Phosphorylation | SLDEKLRTLLYQEHV HHHHHHHHHHHHHCC | 31.39 | 29978859 | |
1598 | Phosphorylation | EKLRTLLYQEHVPTS HHHHHHHHHHCCCCC | 18.24 | 29978859 | |
1604 | O-linked_Glycosylation | LYQEHVPTSSASAGT HHHHCCCCCCCCCCC | 33.94 | 32574038 | |
1604 | Phosphorylation | LYQEHVPTSSASAGT HHHHCCCCCCCCCCC | 33.94 | 29978859 | |
1605 | Phosphorylation | YQEHVPTSSASAGTP HHHCCCCCCCCCCCC | 20.17 | 29978859 | |
1606 | Phosphorylation | QEHVPTSSASAGTPV HHCCCCCCCCCCCCE | 28.81 | 28348404 | |
1608 | Phosphorylation | HVPTSSASAGTPVEV CCCCCCCCCCCCEEE | 29.22 | 28348404 | |
1611 | Phosphorylation | TSSASAGTPVEVGDR CCCCCCCCCEEECCC | 24.71 | 28348404 | |
1631 | Dimethylation | PLRGDQPRSEVCGGD CCCCCCCCHHCCCCC | 39.55 | - | |
1631 | Methylation | PLRGDQPRSEVCGGD CCCCCCCCHHCCCCC | 39.55 | 52720005 | |
1677 | Phosphorylation | GAVMEQGTSSSMTAE CCHHCCCCCCCCCCC | 25.73 | 29978859 | |
1678 | Phosphorylation | AVMEQGTSSSMTAES CHHCCCCCCCCCCCC | 27.52 | 24719451 | |
1679 | Phosphorylation | VMEQGTSSSMTAESS HHCCCCCCCCCCCCC | 24.78 | 29978859 | |
1680 | Phosphorylation | MEQGTSSSMTAESSP HCCCCCCCCCCCCCC | 21.66 | 29978859 | |
1682 | Phosphorylation | QGTSSSMTAESSPRS CCCCCCCCCCCCCCH | 29.26 | 29978859 | |
1685 | Phosphorylation | SSSMTAESSPRSMLG CCCCCCCCCCCHHCC | 43.08 | 27251275 | |
1686 | Phosphorylation | SSMTAESSPRSMLGY CCCCCCCCCCHHCCC | 18.81 | 21815630 | |
1689 | Phosphorylation | TAESSPRSMLGYDRD CCCCCCCHHCCCCCC | 23.03 | - | |
1693 | Phosphorylation | SPRSMLGYDRDGRQV CCCHHCCCCCCCCEE | 12.12 | - | |
1736 | Phosphorylation | DGGEAGESSAEPPPS CCCCCCCCCCCCCCC | 33.65 | 21733846 | |
1765 | Phosphorylation | LGARALGSPRKRPEQ HCHHHCCCCCCCHHH | 23.52 | 23909892 | |
1776 | Phosphorylation | RPEQQDVSSPAKTVG CHHHCCCCCCCEEEE | 38.60 | 23312004 | |
1777 | Phosphorylation | PEQQDVSSPAKTVGR HHHCCCCCCCEEEEE | 28.82 | 29496963 | |
1798 | Phosphorylation | QDEWTLASPHSLRYS CCCEEECCCCCCCCC | 26.68 | 25159151 | |
1801 | Phosphorylation | WTLASPHSLRYSAPP EEECCCCCCCCCCCC | 20.23 | 27251275 | |
1804 | Phosphorylation | ASPHSLRYSAPPDVY CCCCCCCCCCCCCEE | 17.93 | 26657352 | |
1805 | Phosphorylation | SPHSLRYSAPPDVYL CCCCCCCCCCCCEEC | 28.06 | 27732954 | |
1811 | Phosphorylation | YSAPPDVYLDEAPSS CCCCCCEECCCCCCC | 18.80 | 30175587 | |
1817 | Phosphorylation | VYLDEAPSSPDVKLA EECCCCCCCCCHHHH | 62.64 | 25159151 | |
1818 | Phosphorylation | YLDEAPSSPDVKLAV ECCCCCCCCCHHHHH | 24.86 | 25159151 | |
1830 | Phosphorylation | LAVRRAQTASSIEVG HHHHHHHCCCCEEEE | 27.76 | 22468782 | |
1832 | Phosphorylation | VRRAQTASSIEVGVG HHHHHCCCCEEEECC | 34.92 | 22468782 | |
1843 | Phosphorylation | VGVGEPVSSDSGDEG EECCCCCCCCCCCCC | 38.86 | 27732954 | |
1844 | Phosphorylation | GVGEPVSSDSGDEGP ECCCCCCCCCCCCCC | 35.71 | 27732954 | |
1846 | Phosphorylation | GEPVSSDSGDEGPRA CCCCCCCCCCCCCCC | 50.52 | 27732954 | |
1862 | Phosphorylation | PPVQKQASLPVSGSV CCCCCCCCCCCCCCH | 30.61 | 30266825 | |
1866 | Phosphorylation | KQASLPVSGSVAGDF CCCCCCCCCCHHHHH | 24.34 | 30266825 | |
1868 | Phosphorylation | ASLPVSGSVAGDFVK CCCCCCCCHHHHHHH | 10.99 | 30266825 | |
1885 | Phosphorylation | TAFLQRPSRAGSLGP HHHHHCCCCCCCCCC | 36.63 | 28555341 | |
1889 | Phosphorylation | QRPSRAGSLGPETPS HCCCCCCCCCCCCCC | 29.21 | 25159151 | |
1894 | Phosphorylation | AGSLGPETPSRVGMK CCCCCCCCCCCCCCC | 29.69 | 21815630 | |
1896 | Phosphorylation | SLGPETPSRVGMKVP CCCCCCCCCCCCCCC | 47.20 | 20068231 | |
1906 | Phosphorylation | GMKVPTISVTSFHSQ CCCCCEEEEEEECCC | 23.09 | 30177828 | |
1908 | Phosphorylation | KVPTISVTSFHSQSS CCCEEEEEEECCCCC | 20.91 | 30177828 | |
1909 | Phosphorylation | VPTISVTSFHSQSSY CCEEEEEEECCCCCC | 20.85 | 30177828 | |
1912 | Phosphorylation | ISVTSFHSQSSYISS EEEEEECCCCCCCCC | 29.73 | 30177828 | |
1914 | Phosphorylation | VTSFHSQSSYISSDN EEEECCCCCCCCCCC | 28.29 | 30177828 | |
1915 | Phosphorylation | TSFHSQSSYISSDND EEECCCCCCCCCCCC | 20.88 | 30177828 | |
1916 | Phosphorylation | SFHSQSSYISSDNDS EECCCCCCCCCCCCH | 15.29 | 30177828 | |
1918 | Phosphorylation | HSQSSYISSDNDSEL CCCCCCCCCCCCHHH | 24.33 | 30177828 | |
1919 | Phosphorylation | SQSSYISSDNDSELE CCCCCCCCCCCHHHC | 30.76 | 30177828 | |
1923 | Phosphorylation | YISSDNDSELEDADI CCCCCCCHHHCHHHH | 50.78 | 30177828 | |
1936 | Phosphorylation | DIKKELQSLREKHLK HHHHHHHHHHHHHHH | 41.86 | 21406692 | |
2009 | Phosphorylation | RQLKVVASSTGHLAD HHHHHHHHCCCCCCC | 19.47 | 27732954 | |
2010 | Phosphorylation | QLKVVASSTGHLADS HHHHHHHCCCCCCCC | 28.77 | 27732954 | |
2011 | Phosphorylation | LKVVASSTGHLADSS HHHHHHCCCCCCCCC | 26.56 | 27732954 | |
2056 | O-linked_Glycosylation | QPCSVRASLSSDICS CCCCCEEECCCCHHH | 20.44 | 32574038 | |
2056 | Phosphorylation | QPCSVRASLSSDICS CCCCCEEECCCCHHH | 20.44 | - | |
2063 | Phosphorylation | SLSSDICSGLASDGG ECCCCHHHCCCCCCC | 36.86 | 29116813 | |
2067 | Phosphorylation | DICSGLASDGGGARG CHHHCCCCCCCCCCC | 41.66 | 11280764 | |
2078 | Phosphorylation | GARGQGWTVYHPTSE CCCCCCCEEECCCCC | 20.29 | - | |
2091 | Phosphorylation | SERVTYKSSSKPRAR CCCEEECCCCCCCHH | 29.45 | 27251275 | |
2101 | Phosphorylation | KPRARFLSGPVSVSI CCCHHHCCCCCHHHH | 38.04 | 24719451 | |
2110 | Phosphorylation | PVSVSIWSALKRLCL CCHHHHHHHHHHHHC | 23.27 | 27251275 | |
2128 | Phosphorylation | HSSRSSTSSLAPGPE CCCCCCCCCCCCCCC | 25.88 | - | |
2129 | Phosphorylation | SSRSSTSSLAPGPEP CCCCCCCCCCCCCCC | 28.74 | - | |
2155 | Ubiquitination | VNNSNNKKGTFTDDL ECCCCCCCEECCHHH | 66.36 | - | |
2157 | Phosphorylation | NSNNKKGTFTDDLHK CCCCCCEECCHHHHH | 32.04 | 25159151 | |
2159 | Phosphorylation | NNKKGTFTDDLHKLV CCCCEECCHHHHHHH | 28.57 | 28450419 | |
2170 | Phosphorylation | HKLVDEWTSKTVGAA HHHHHHHHHCCCCHH | 20.49 | 22210691 | |
2171 | Phosphorylation | KLVDEWTSKTVGAAQ HHHHHHHHCCCCHHH | 27.66 | 22210691 | |
2173 | Phosphorylation | VDEWTSKTVGAAQLK HHHHHHCCCCHHHHH | 24.76 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of WNK2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WNK2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WNK2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SGK1_HUMAN | SGK1 | physical | 20525693 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"WNK2 is a novel regulator of essential neuronal cation-chloridecotransporters."; Rinehart J., Vazquez N., Kahle K.T., Hodson C.A., Ring A.M.,Gulcicek E.E., Louvi A., Bobadilla N.A., Gamba G., Lifton R.P.; J. Biol. Chem. 286:30171-30180(2011). Cited for: FUNCTION, TISSUE SPECIFICITY, AND PHOSPHORYLATION AT SER-45; SER-560;SER-1150; SER-1262; SER-1588; SER-1685; SER-1736; SER-1817; SER-1818;SER-1862 AND SER-2067. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1817 AND SER-1818, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49; SER-1817; SER-1818;SER-1862 AND SER-1889, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1817 AND SER-1818, ANDMASS SPECTROMETRY. |